Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Physiological Pharmacokinetic Models: Incorporating Hepatic Transporter-Mediated Clearance01:07

Physiological Pharmacokinetic Models: Incorporating Hepatic Transporter-Mediated Clearance

257
Drug transporters are critical in drug absorption, distribution, and excretion processes. They should be included in physiological-based pharmacokinetic (PBPK) models, which help predict human drug disposition. However, predicting this is challenging during drug development, especially when liver transport is involved. However, with a realistic representation of body transport processes, an accurate model may be possible.
A recent model describes pravastatin's hepatobiliary excretion,...
257
Effect of Hepatic Disease on Pharmacokinetics: Active Drug, Metabolite and Fraction of Metabolized Drug01:14

Effect of Hepatic Disease on Pharmacokinetics: Active Drug, Metabolite and Fraction of Metabolized Drug

202
In pharmacotherapy, monitoring drug concentrations is paramount, especially for drugs whose therapeutic effects hinge on both the active compound and its metabolite. Hepatic impairment profoundly influences drug potency by altering liver function. If the drug is more potent than its metabolite, impaired liver function amplifies drug activity due to elevated drug concentration levels. Conversely, if the metabolite holds greater potency, diminished liver function diminishes drug activity by...
202
Pneumonia II: Pathophysiology01:29

Pneumonia II: Pathophysiology

2.5K
The pathophysiology of pneumonia involves the following steps:
2.5K
Microorganisms in Medicine and Therapeutics01:29

Microorganisms in Medicine and Therapeutics

922
Microorganisms play a fundamental role in vaccine development, gene therapy, and therapeutic production. Their biological properties are harnessed to advance medicine and public health. Beyond immunization, microorganisms contribute to gut health, antibiotic synthesis, and genetic disease treatment.Live Attenuated and Inactivated VaccinesLive attenuated vaccines, such as the measles, mumps, and rubella (MMR) vaccine, utilize weakened forms of pathogens to closely resemble natural infections.
922
Biopharmaceutics and Pharmacokinetics: Overview01:28

Biopharmaceutics and Pharmacokinetics: Overview

3.2K
Understanding drugs, drug products, and their performance in pharmaceutical science is pivotal. Drugs, whether simple molecules or complex compounds, are designed to interact with the body's biological systems to diagnose, treat, or prevent diseases. Drug products include various delivery systems such as tablets, capsules, injections, and inhalers. The performance of these drug products is gauged by their ability to deliver the active ingredient to the desired site of action at the...
3.2K
Nursing Clinical Information System01:27

Nursing Clinical Information System

1.2K
Nursing Clinical Information System (NCIS)
A Nursing Clinical Information System (NCIS) is a specialized type of healthcare information system tailored to meet the unique needs of nursing practice. It incorporates the principles of nursing informatics to streamline information management and improve the quality of care delivery.
Critical attributes of NCIS include:
1.2K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Automated generation of impressions in abdominal radiology reports using an artificial intelligence-based tool: performance compared to manual impressions.

Abdominal radiology (New York)·2026
Same author

Regulatory landscape of widespread stop codon readthrough in <i>Drosophila</i>.

bioRxiv : the preprint server for biology·2026
Same author

A Prospective Comparative Non-randomized Study of Ketofol Versus Midazolam Sedation in Flexible Bronchoscopy.

Cureus·2026
Same author

Predictive accuracy of a perioperative hemodynamic indices-based prediction model for moderate-to-severe acute kidney injury after orthotopic heart transplantation.

Surgery·2026
Same author

Inhibition of the IRE1α/ASK1/JNK signaling pathway ameliorates perioperative neurocognitive disorder in aged mice following abdominal surgery.

Brain research·2026
Same author

Reevaluating the role of beta2-microglobulin: new insights on selective vulnerability in ALS pathology.

Acta neuropathologica·2026

Related Experiment Video

Updated: Jan 11, 2026

Label-Free Quantitative Proteomics Workflow for Discovery-Driven Host-Pathogen Interactions
05:37

Label-Free Quantitative Proteomics Workflow for Discovery-Driven Host-Pathogen Interactions

Published on: October 20, 2020

7.4K

CD-CODE 2.0: an enhanced condensate knowledgebase integrating pathobiology, condensate modulating drugs, and

Ksenia Kuznetsova1,2, Maxim Scheremetjew1,2, Jialin Yin1,2

  • 1Max Planck Institute of Molecular Cell Biology and Genetics, Pfotenhauerstraße 108, 01307 Dresden, Germany.

Nucleic Acids Research
|November 9, 2025
PubMed
Summary

CD-CODE 2.0 is an upgraded database for studying biological condensates. It now includes new data types and improved search capabilities to advance condensate biology research and drug discovery.

More Related Videos

A Toolkit to Enable Hydrocarbon Conversion in Aqueous Environments
20:28

A Toolkit to Enable Hydrocarbon Conversion in Aqueous Environments

Published on: October 2, 2012

14.6K
High-Throughput Transcriptome Analysis for Investigating Host-Pathogen Interactions
14:58

High-Throughput Transcriptome Analysis for Investigating Host-Pathogen Interactions

Published on: March 5, 2022

4.7K

Related Experiment Videos

Last Updated: Jan 11, 2026

Label-Free Quantitative Proteomics Workflow for Discovery-Driven Host-Pathogen Interactions
05:37

Label-Free Quantitative Proteomics Workflow for Discovery-Driven Host-Pathogen Interactions

Published on: October 20, 2020

7.4K
A Toolkit to Enable Hydrocarbon Conversion in Aqueous Environments
20:28

A Toolkit to Enable Hydrocarbon Conversion in Aqueous Environments

Published on: October 2, 2012

14.6K
High-Throughput Transcriptome Analysis for Investigating Host-Pathogen Interactions
14:58

High-Throughput Transcriptome Analysis for Investigating Host-Pathogen Interactions

Published on: March 5, 2022

4.7K

Area of Science:

  • Biochemistry
  • Molecular Biology
  • Systems Biology

Background:

  • Biological condensates are crucial for cellular organization and function.
  • Understanding condensate biology is key to addressing various diseases.
  • Previous versions of CD-CODE provided foundational data on condensates.

Purpose of the Study:

  • To introduce CD-CODE 2.0, an enhanced web application and database for condensate research.
  • To expand the scope of condensate data to include nucleic acids, infectious agents, drugs, and disease links.
  • To improve data accessibility and enable systems-level analysis for hypothesis generation and therapeutic discovery.

Main Methods:

  • Development of an enhanced web application and database (CD-CODE 2.0).
  • Integration of new data categories: nucleic acid components, infectious condensates, modulating drugs, and disease-linked condensates.
  • Implementation of enhanced search functions, programmatic access, and a relational architecture.

Main Results:

  • CD-CODE 2.0 offers expanded data on various aspects of condensate biology.
  • The application provides enhanced search and programmatic access to condensate-related information.
  • The relational architecture facilitates interconnectivity with other major biomedical databases.

Conclusions:

  • CD-CODE 2.0 significantly enhances the utility of condensate data for biomedical research.
  • The platform supports systems-level insights, accelerating hypothesis generation.
  • This resource is poised to advance therapeutic discovery in condensate biology.